Related references
Note: Only part of the references are listed.Toward Gene Transfer Nanoparticles as Therapeutics
Erin W. Kavanagh et al.
ADVANCED HEALTHCARE MATERIALS (2022)
Ceramide-1-Phosphate Is Involved in Therapy-Induced Senescence
Alec Millner et al.
ACS CHEMICAL BIOLOGY (2022)
Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment
Alhaji H. Janneh et al.
CANCERS (2022)
Cell surface sphingomyelin: key role in cancer initiation, progression, and immune evasion
Hatem Tallima et al.
LIPIDS IN HEALTH AND DISEASE (2021)
Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype
Trishna Pani et al.
CELL DEATH & DISEASE (2021)
A hydrogel-based implantable multidrug antitubercular formulation outperforms oral delivery
Sanjay Pal et al.
NANOSCALE (2021)
Hydrogel-mediated delivery of celastrol and doxorubicin induces a synergistic effect on tumor regression via upregulation of ceramides
Nihal Medatwal et al.
NANOSCALE (2020)
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin et al.
BREAST CANCER RESEARCH (2020)
Overcoming the Reticuloendothelial System Barrier to Drug Delivery with a Don't-Eat-Us Strategy
Yixuan Tang et al.
ACS NANO (2019)
A Localized Chimeric Hydrogel Therapy Combats Tumor Progression through Alteration of Sphingolipid Metabolism
Sanjay Pal et al.
ACS CENTRAL SCIENCE (2019)
Multiple actions of doxorubicin on the sphingolipid network revealed by flux analysis
Justin M. Snider et al.
JOURNAL OF LIPID RESEARCH (2019)
Targeted therapeutic options and future perspectives for HER2-positive breast cancer
Jiani Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
A nanogel based oral gene delivery system targeting SUMOylation machinery to combat gut inflammation
Prabhu Srinivas Yavvari et al.
NANOSCALE (2019)
Advances in the systemic treatment of triple-negative breast cancer
J. M. Lebert et al.
CURRENT ONCOLOGY (2018)
Towards an arthritis flare-responsive drug delivery system
Nitin Joshi et al.
NATURE COMMUNICATIONS (2018)
Unbiased Lipidomic Profiling of Triple-Negative Breast Cancer Tissues Reveals the Association of Sphingomyelin Levels with Patient Disease-Free Survival
Preeti Purwaha et al.
METABOLITES (2018)
Sphingolipid metabolism in cancer signalling and therapy
Besim Ogretmen
NATURE REVIEWS CANCER (2018)
Lipid metabolic reprogramming in cancer cells
S. Beloribi-Djefaflia et al.
ONCOGENESIS (2016)
Triple positive breast cancer: A distinct subtype?
Patrizia Vici et al.
CANCER TREATMENT REVIEWS (2015)
Differential Regulation of Specific Sphingolipids in Colon Cancer Cells during Staurosporine-Induced Apoptosis
Virginia del Solar et al.
CHEMISTRY & BIOLOGY (2015)
Determination of lipidomic differences between human breast cancer and surrounding normal tissues using HILIC-HPLC/ESI-MS and multivariate data analysis
Eva Cifkova et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2015)
The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death
Oleksandr Pastukhov et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Ceramide Kinase Promotes Tumor Cell Survival and Mammary Tumor Recurrence
Ania W. Payne et al.
CANCER RESEARCH (2014)
Biological subtypes of breast cancer: Prognostic and therapeutic implications
Ozlem Yersal et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Ceramide-orchestrated signalling in cancer cells
Samy A. F. Morad et al.
NATURE REVIEWS CANCER (2013)
Dysregulation of sphingolipid metabolism in cancer
Lindsay K. Ryland et al.
CANCER BIOLOGY & THERAPY (2011)
A method for visualization of omic datasets for sphingolipid metabolism to predict potentially interesting differences
Amin A. Momin et al.
JOURNAL OF LIPID RESEARCH (2011)
Sphingolipids and expression regulation of genes in cancer
Gauri A. Patwardhan et al.
PROGRESS IN LIPID RESEARCH (2011)
Activation of protein kinase C-α is essential for stimulation of cell proliferation by ceramide 1-phosphate
Patricia Gangoiti et al.
FEBS LETTERS (2010)
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
K. David Voduc et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
An update on sphingosine-1-phosphate and other sphingolipid mediators
Henrik Fyrst et al.
NATURE CHEMICAL BIOLOGY (2010)
Sphingosine 1-phosphate and cancer
Nigel J. Pyne et al.
NATURE REVIEWS CANCER (2010)
Ceramide 1-phosphate (C1P) promotes cell migration Involvement of a specific C1P receptor
Maria H. Granado et al.
CELLULAR SIGNALLING (2009)
Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer
Eugen Ruckhaeberle et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Principles of bioactive lipid signalling: lessons from sphingolipids
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Ceramide 1-phosphate/ceramide, a switch between life and death
Antonio Gomez-Munoz
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Sphingolipid targets in cancer therapy
DE Modrak et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Ceramide-1-phosphate promotes cell survival through activation of the phosphatidylinositol 3-kinase/protein kinase B pathway
A Gómez-Muñoz et al.
FEBS LETTERS (2005)
The ceramide-centric universe of lipid-mediated cell regulation: Stress encounters of the lipid kind.
YA Hannun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
